ASH Scientific Workshop “Interplay between coagulation and malignancy”
The American Society of Hematology (ASH) is the world’s largest professional society serving clinicians and...
Congress reports
Modeling predictors and outcomes in myeloproliferative neoplasms and thrombosis
Myeloproliferative neoplasms (MPNs) are characterized by clonal expansion of abnormal hematopoietic stem cells, which...
Late-breaking research: relationship between PAI-1 cancer cell expression and thrombosis in pancreatic cancer
The urokinase plasminogen activator system is a serine protease family, including urokinase-type plasminogen activator...
Interplay between the hematologic system and solid tumor progression
A relationship between coagulation and cancer has been known since the 19th century, when Armand Trousseau first...
miRNA and its role in cancer-associated thrombosis
Cancer-associated thrombosis (CAT) is one of the leading causes of non-cancer-related deaths in patients with cancer...
ISTH 2020 CONGRESS: CANCER-ASSOCIATED THROMBOSIS ABSTRACT OVERVIEW
The recent International Society on Thrombosis and Haemostasis (ISTH) Congress, held on 12–14 July 2020, as a virtual...
COVID-19 Hemostasis and Malignancy: the Bergamo Experience
The COVID-19 pandemic took one of its biggest tolls on Italy, and especially in the northern area, in Lombardy. In this...
Venous thromboembolism: News from the Annual Meeting of the American Society of Hematology (ASH) on prevention and treatment
The Annual Meeting of the American Society of Hematology (ASH) was held on 7−10 December 2019 in Orlando (FL, USA)....
Cancer-associated Thrombosis at ASH 2019
We are happy to announce that ASH will be sponsoring a Scientific Workshop on Cancer Associated Thrombosis. The goal of...
ISTH 2019: The CAT treatment, from trials to clinical practice
Straight from ISTH 2019 Alok Khorana tells us what’s new in the CAT...